Mira Kharbanda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mira Kharbanda has a total of 245 co-authors. Here are the top co-authors by number of shared publications:
- David R. FitzPatrick
MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK
2 shared publications - Malcolm Donaldson
Section of Child Health, Glasgow University School of Medicine, Glasgow, UK
2 shared publications Morag N. Collinson
Wessex Regional Genetics Laboratory Salisbury District Hospital Salisbury Hampshire UK
2 shared publicationsVictoria Murday
West of Scotland Clinical Genetics Service, Level 2A Laboratory Medicine Building, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, G51 4TF, UK
2 shared publicationsAlan Fryer
Department of Clinical Genetics, Liverpool Women's NHS Foundation Trust, Liverpool, L8 7SS, UK
1 shared publication- Alastair Harvey Maclennan
Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia; Robinson Research Institute, The University of Adelaide, Adelaide, South Australia, Australia
1 shared publication
Latest Publications
- Open Access
- 1 December 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (12) , 2342-2345
Pigmentary anomaly caused by mosaic 3q22.2q29 duplication
A 39-year-old woman sought advice regarding potential risks to her offspring due to previous possible diagnosis of incontinentia pigmenti. She had linear hyperpigmentation along the lines of Blaschko affecting the upper and lower limbs, and skin-coloured papules on the left palm. Ophthalmoscopy revealed hypopigmented spots in the macular region of the retina in each eye due to focal areas of depigmentation of the retinal pigment epithelium. An array comparative genomic hybridization on DNA extracted from a skin biopsy revealed a 63.63-Mb duplication, arr[GRCh37] 3q22.2q29(134212001_197837069)x3, on the long arm of chromosome 3. This case is an example of genetic mosaicism resulting from a de novo genetic defect arising at some point in embryonic development. Click here for the corresponding questions to this CME article.
- 1 December 2022
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 47 (12) , 2342-2345
Open AccessPigmentary anomaly caused by mosaic 3q22.2q29 duplication
A 39-year-old woman sought advice regarding potential risks to her offspring due to previous possible diagnosis of incontinentia pigmenti. She had linear hyperpigmentation along the lines of Blaschko affecting the upper and lower limbs, and skin-coloured papules on the left palm. Ophthalmoscopy revealed hypopigmented spots in the macular region of the retina in each eye due to focal areas of depigmentation of the retinal pigment epithelium. An array comparative genomic hybridization on DNA extracted from a skin biopsy revealed a 63.63-Mb duplication, arr[GRCh37] 3q22.2q29(134212001_197837069)x3, on the long arm of chromosome 3. This case is an example of genetic mosaicism resulting from a de novo genetic defect arising at some point in embryonic development. Click here for the corresponding questions to this CME article.
- Open Access
- 9 September 2022
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (11) , 2351-2366
Genomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
- 9 September 2022
- Published by Elsevier in Genetics in Medicine
- Vol. 24 (11) , 2351-2366
Open AccessGenomic and phenotypic characterization of 404 individuals with neurodevelopmental disorders caused by CTNNB1 variants
- 22 April 2020
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 160 (4) , 185-192
Directly Transmitted 12.3-Mb Deletion with a Consistent Phenotype in the Variable 11q21q22.3 Region
A phenotype is emerging for the proximal pair of G-dark bands in 11q (11q14.1 and q14.3) but not yet for the distal pair (11q22.1 and q22.3). A mother and daughter with the same directly transmitted 12.3-Mb interstitial deletion of 11q21q22.3 (GRCh37: 93,551,765-105,817,723) both had initial feeding difficulties and failure to thrive, speech delay, learning difficulties, and mild dysmorphism. Among 17 patients with overlapping deletions, developmental or speech delay, dysmorphism, hypotonia, intellectual disability or learning difficulties, short stature, and coloboma were each found in 2 or more. These results may provide the basis for a consistent phenotype for this region. Among the 53 deleted and additional breakpoint genes, CNTN5, YAP1, and GRI4 were the most likely candidates. Non-penetrance of haploinsufficient genes and dosage compensation among related genes may account for the normal cognition in the mother and variable phenotypes that can extend into the normal range.
- 22 April 2020
- Published by S. Karger AG in Cytogenetic and Genome Research
- Vol. 160 (4) , 185-192
Directly Transmitted 12.3-Mb Deletion with a Consistent Phenotype in the Variable 11q21q22.3 Region
A phenotype is emerging for the proximal pair of G-dark bands in 11q (11q14.1 and q14.3) but not yet for the distal pair (11q22.1 and q22.3). A mother and daughter with the same directly transmitted 12.3-Mb interstitial deletion of 11q21q22.3 (GRCh37: 93,551,765-105,817,723) both had initial feeding difficulties and failure to thrive, speech delay, learning difficulties, and mild dysmorphism. Among 17 patients with overlapping deletions, developmental or speech delay, dysmorphism, hypotonia, intellectual disability or learning difficulties, short stature, and coloboma were each found in 2 or more. These results may provide the basis for a consistent phenotype for this region. Among the 53 deleted and additional breakpoint genes, CNTN5, YAP1, and GRI4 were the most likely candidates. Non-penetrance of haploinsufficient genes and dosage compensation among related genes may account for the normal cognition in the mother and variable phenotypes that can extend into the normal range.
- 1 February 2019
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 104 (2) , 319-330
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder
- 1 February 2019
- Published by Elsevier in The American Journal of Human Genetics
- Vol. 104 (2) , 319-330
ZMIZ1 Variants Cause a Syndromic Neurodevelopmental Disorder
- 1 May 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (5) , 257-260
A further case of brain-lung-thyroid syndrome with deletion proximal to NKX2-1
- 1 May 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (5) , 257-260
A further case of brain-lung-thyroid syndrome with deletion proximal to NKX2-1
- Open Access
- 1 May 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (5) , 233-238
Long QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation
- 1 May 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (5) , 233-238
Open AccessLong QT syndrome and left ventricular noncompaction in 4 family members across 2 generations with KCNQ1 mutation
- Open Access
- 1 February 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (2) , 130-135
Clinical features associated with CTNNB1 de novo loss of function mutations in ten individuals
- 1 February 2017
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 60 (2) , 130-135
Open AccessClinical features associated with CTNNB1 de novo loss of function mutations in ten individuals
- 1 June 2016
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 59 (6-7) , 310-314
Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome
- 1 June 2016
- Published by Elsevier in European Journal of Medical Genetics
- Vol. 59 (6-7) , 310-314
Partial deletion of TCF4 in three generation family with non-syndromic intellectual disability, without features of Pitt-Hopkins syndrome
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 29 (12) , 1407-1412
A case of 46,XX dysgenesis and marked tall stature; the need for caution in interpreting array comparative genomic hybridization (CGH)
Background: Gonadal dysgenesis with an apparently normal 46,XX karyotype is a rare cause of hypergonadotrophic hypogonadism. Tall stature is not a widely recognized association. Case report: A 15-year-old girl presented with primary amenorrhoea. Examination showed a non-dysmorphic girl of normal intellect with no breast development (Tanner stage B1P4A1) who was tall compared with her parents: height standard deviation score (SDS) +1.56 vs. midparental height of +0.23 SDS, and slim build (weight −0.13 SDS). Investigations showed a 46,XX karyotype, elevated gonadotropins (FSH 119 and LH 33.7 IU/L), serum estradiol Conclusions: Caution is needed in interpreting small changes with array CGH, particularly with the older assays. We postulate that the genetic change causing 46,XX gonadal dysgenesis in our patient may have also resulted in unsuppressed somatic growth. More critical height assessment, including parental height measurement, of future patients with 46,XX gonadal dysgenesis is recommended in order to determine whether or not a true association with tall stature may be present in certain cases.
- 1 January 2016
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 29 (12) , 1407-1412
A case of 46,XX dysgenesis and marked tall stature; the need for caution in interpreting array comparative genomic hybridization (CGH)
Background: Gonadal dysgenesis with an apparently normal 46,XX karyotype is a rare cause of hypergonadotrophic hypogonadism. Tall stature is not a widely recognized association. Case report: A 15-year-old girl presented with primary amenorrhoea. Examination showed a non-dysmorphic girl of normal intellect with no breast development (Tanner stage B1P4A1) who was tall compared with her parents: height standard deviation score (SDS) +1.56 vs. midparental height of +0.23 SDS, and slim build (weight −0.13 SDS). Investigations showed a 46,XX karyotype, elevated gonadotropins (FSH 119 and LH 33.7 IU/L), serum estradiol Conclusions: Caution is needed in interpreting small changes with array CGH, particularly with the older assays. We postulate that the genetic change causing 46,XX gonadal dysgenesis in our patient may have also resulted in unsuppressed somatic growth. More critical height assessment, including parental height measurement, of future patients with 46,XX gonadal dysgenesis is recommended in order to determine whether or not a true association with tall stature may be present in certain cases.
- 4 September 2014
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 100 (1) , 24-29
How to use… microarray comparative genomic hybridisation to investigate developmental disorders
Array-comparative genomic hybridisation (array-CGH) is a relatively new test that permits close scrutiny of chromosomal structure to detect genomic microdeletions and microduplications that are invisible in a conventional karyotype. Array-CGH is now the ‘first-line’ genetic test in the investigation of early developmental impairments and learning difficulties, especially if the clinical picture includes dysmorphism, abnormal growth, congenital anomalies, epilepsy and autism, alone or in combination. However, due to the array-CGH report's technical content and the uncertain clinical significance of many genomic findings, the results of array-CGH studies need careful interpretation. Array-CGH trebles the frequency of diagnosis compared with conventional karyotyping, but collaborative working, involving paediatricians, clinical geneticists and clinical scientists, is most important for interpretation of the results of new genomic investigations in everyday clinical practice.
- 4 September 2014
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 100 (1) , 24-29
How to use… microarray comparative genomic hybridisation to investigate developmental disorders
Array-comparative genomic hybridisation (array-CGH) is a relatively new test that permits close scrutiny of chromosomal structure to detect genomic microdeletions and microduplications that are invisible in a conventional karyotype. Array-CGH is now the ‘first-line’ genetic test in the investigation of early developmental impairments and learning difficulties, especially if the clinical picture includes dysmorphism, abnormal growth, congenital anomalies, epilepsy and autism, alone or in combination. However, due to the array-CGH report's technical content and the uncertain clinical significance of many genomic findings, the results of array-CGH studies need careful interpretation. Array-CGH trebles the frequency of diagnosis compared with conventional karyotyping, but collaborative working, involving paediatricians, clinical geneticists and clinical scientists, is most important for interpretation of the results of new genomic investigations in everyday clinical practice.